Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
327.00    -8.40 (-2.50%)
Bid:
326.80
Ask:
328.20
Spread: 1.40 (0.428%)
Market Cap: £716.36m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Director/PDMR Shareholding

31 Jan 2025 07:30

RNS Number : 3602V
Burford Capital Limited
31 January 2025
 

 

January 30, 2025

 

Released out of hours on January 30, 2025, and queued for release via RNS upon its reopening on January 31, 2025.

 

Notifications of Transactions by Persons Discharging Managerial Responsibilities

 

Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, provides the following notifications of transactions by persons discharging managerial responsibilities (each, a "PDMR").

 

Pursuant to the previously announced written executive share liquidity plans (the "Plans") for each PDMR, which were further explained in Burford's report on Form 6-K furnished to the US Securities and Exchange Commission on August 8, 2024, on January 28, 2025, Merrill Lynch sold on behalf of Chief Executive Officer Christopher Bogart, Chief Investment Officer Jonathan Molot, President Aviva Will and Vice Chair David Perla in aggregate 190,500 Burford's ordinary shares of nil par value ("Shares"). The timing and execution of the sales are managed by Merrill Lynch according to pre-set parameters set forth in the Plans. The breakdown of these sales of Shares is as follows: 90,000 Shares by Mr Bogart, 90,000 Shares by Mr Molot, 7,500 Shares by Ms Will and 3,000 Shares by Mr Perla.

 

The Plans are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the US Securities Exchange Act of 1934, as amended, and to comply with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

The Notification of Dealing Forms for the transactions set forth above are included at the end of this announcement.

 

 

For further information, please contact:

 

Burford Capital Limited

For investor and analyst inquiries:

Americas: Josh Wood, Head of Investor Relations - email

+1 212 516 5824

EMEA & Asia: Rob Bailhache, Head of EMEA & Asia Investor Relations - email

+44 (0)20 3530 2023

For press inquiries:

David Helfenbein, Vice President, Public Relations - email

+1 212 516 5824

Deutsche Numis - NOMAD and Joint Broker

+44 (0)20 7260 1000

Giles Rolls

Charlie Farquhar

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

James Umbers

Berenberg - Joint Broker

+44 (0)20 3207 7800

Toby Flaux

James Thompson

Yasmina Benchekroun

 

 

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its offices in New York, London, Chicago, Washington, DC, Singapore, Dubai and Hong Kong.

 

For more information, please visit www.burfordcapital.com.

 

 

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This announcement does not constitute an offer of any Burford private fund. Burford Capital Investment Management LLC, which acts as the fund manager of all Burford private funds, is registered as an investment adviser with the US Securities and Exchange Commission. The information provided in this announcement is for informational purposes only. Past performance is not indicative of future results. The information contained in this announcement is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in any of Burford private funds). Any such offer or solicitation may be made only by means of a final confidential private placement memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, Burford and its representatives may from time to time make other oral or written statements that are forward-looking, including in its periodic reports that Burford files with, or furnishes to, the US Securities and Exchange Commission, other information made available to Burford's security holders and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Burford cautions that forward-looking statements are not guarantees of future performance and are based on numerous assumptions, expectations, projections, intentions and beliefs and that Burford's actual results of operations, including its financial position and liquidity, and the development of the industry in which it operates, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this announcement. Significant factors that may cause actual results to differ from those Burford expects include, among others, those discussed under "Risk Factors" in Burford's annual report on Form 20-F for the year ended December 31, 2023 filed with the US Securities and Exchange Commission on March 28, 2024 and other reports or documents that Burford files with, or furnishes to, the US Securities and Exchange Commission from time to time. In addition, even if Burford's results of operations, including its financial position and liquidity, and the development of the industry in which it operates are consistent with the forward-looking statements contained in this announcement, those results of operations or developments may not be indicative of results of operations or developments in subsequent periods.

 

Except as required by law, Burford undertakes no obligation to update or revise the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Christopher Bogart

2

Reason for the notification

 

(a) Position/status

A PDMR occupying the position of Chief Executive Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Sale of Ordinary Shares

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$14.61

90,000

 

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

28 January 2025

 

(f) Place of the transaction

New York Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Jonathan Molot

2

Reason for the notification

 

(a) Position/status

A PDMR occupying the position of Chief Investment Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Sale of Ordinary Shares

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$14.61

90,000

 

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

28 January 2025

 

(f) Place of the transaction

New York Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Aviva Will

2

Reason for the notification

 

(a) Position/status

A PDMR occupying the position of President

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Sale of Ordinary Shares

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$14.61

7,500

 

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

28 January 2025

 

(f) Place of the transaction

New York Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

David Perla

2

Reason for the notification

 

(a) Position/status

A PDMR occupying the position of Vice Chair

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Sale of Ordinary Shares

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$14.61

3,000

 

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

28 January 2025

 

(f) Place of the transaction

New York Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDBLFXEFLEBBZ
Date   Source Headline
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering
7th Jul 202512:57 pmRNSPrivate Offering of Senior Notes
3rd Jul 202511:00 amRNSIssue of New Shares in Connection With LTIP
2nd Jul 20255:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.